Skip to main content

Aura Biosciences gets $30M round; investors include Termeer estate

Participants in the Series C round announced on Thursday include the estate of the Genzyme founder, who died in May 2017.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.